| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8735214 | Hepatobiliary & Pancreatic Diseases International | 2018 | 7 Pages |
Abstract
Lower HSD17B13 in peritumoral tissues was associated with worse recurrence free survival and overall survival of HCC patients. HSD17B13 delayed G1/S progression of HCC cells. HSD17B13 may be a therapeutic target for the treatment of HCC.
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
Jun Chen, Jian-Yong Zhuo, Fan Yang, Zhi-Kun Liu, Lin Zhou, Hai-Yang Xie, Xiao Xu, Shu-Sen Zheng,